Agile Therapeutics Inc (NASDAQ: AGRX) is -69.69% lower on its value in year-to-date trading and has touched a low of $0.70 and a high of $14.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AGRX stock was last observed hovering at around $0.71 in the last trading session, with the day’s loss setting it -0.12%.
Currently trading at $0.59, the stock is -33.05% and -53.53% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.7 million and changing -16.27% at the moment leaves the stock -72.15% off its SMA200. AGRX registered -94.50% loss for a year compared to 6-month loss of -71.31%. The firm has a 50-day simple moving average (SMA 50) of $0.07 and a 200-day simple moving average (SMA200) of -$0.12.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -50.74% gain in the last 1 month and extending the period to 3 months gives it a -71.02%, and is -22.73% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.12% over the week and 11.64% over the month.
Agile Therapeutics Inc (AGRX) has around 22 employees, a market worth around $1.75M and $19.97M in sales. Profit margin for the company is -69.73%. Distance from 52-week low is -15.56% and -95.92% from its 52-week high.
Agile Therapeutics Inc quarterly earnings per share for the current quarter are estimated at -$0.54 with sales reaching $9.2M over the same period., but quarterly earnings will post 133.20% year-over-year. Quarterly sales are estimated to grow 130.20% in year-over-year returns.
22 institutions hold shares in Agile Therapeutics Inc (AGRX), with institutional investors hold 10.25% of the company’s shares. The shares outstanding are 2.96M, and float is at 2.85M with Short Float at 7.79%. Institutions hold 10.13% of the Float.
The top institutional shareholder in the company is Armistice Capital, LLC with over 0.12 million shares valued at $0.36 million. The investor’s holdings represent 6.33% of the AGRX Shares outstanding. As of Jun 29, 2023, the second largest holder is State Street Corporation with 10843.0 shares valued at $31986.0 to account for 0.56% of the shares outstanding. The other top investors are Blackrock Inc. which holds 6061.0 shares representing 0.31% and valued at over $17879.0, while Tower Research Capital LLC (TRC) holds 0.14% of the shares totaling 2712.0 with a market value of $8000.0.
